May 13, 2010 – Madison, WI – Memory loss study on brain health supplement, Prevagen, supports 2010 Older Americans Month theme, “Age Strong! Live Long!” The Prevagen Quality of Life Study was conducted by Quincy Bioscience, makers of Prevagen, a brain cell protection supplement. Study results of older Americans taking Prevagen show reduced forgetfulness, reduced need for reminders, help with word recall and improved memory (http://www.prevagen.com/memoryloss/) in 30 days.

When Older Americans Month, (formerly Senior Citizens Month), was established in 1963, only 17 million living Americans reached their 65th birthdays. In 2008, (the latest year for which data is available), the older population–persons 65 years or older–numbered 38.9 million. By 2030 there will be about 72.1 million older persons, more than twice their number in 2000. Persons reaching age 65 have an average life expectancy of an additional 18.6 years (19.8 years for females and 17.1 years for males). For more information on Older Americans Month and older Americans visithttp://www.aoa.gov/aoaroot/press_room/observances/oam/oa …

“My life’s work is committed to helping older Americans ‘Age Strong, Live Long!’ and we have completed many neuroscience research studies to address the healthy brain aspect of this theme,” says Mark Underwood, neuroscience researcher and president of Prevagen’s manufacturer, Quincy Bioscience. “We have learned that the calcium-binding proteins that protect our brain cells deplete with age. We developed Prevagen which is the only all-natural brain supplement that can replace these proteins and prevent memory loss.”

Underwood, whose interest in neuroscience research began after witnessing two of his family members develop memory loss, says The Prevagen Quality of Life Study is one more study we’ve conducted with Prevagen showing the benefits a calcium-binding protein supplement on memory loss symptoms by helping to keep brain cells alive which can result in a healthier brain, a sharper mind, clearer thinking, and better memory.” To read the Prevagen Quality of Life Study visithttp://www.prevagen.com/files/PRV_Memorystudy_packet.pdf.

Memory loss supplement Prevagen is manufactured by Quincy Bioscience (http://www.quincybioscience.com), a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company’s products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for dietary supplement and pharmaceutical products. The company’s first product, Prevagen (www.prevagen.com), was launched in the fall of 2007 and is intended to supplement the loss of critical calcium-binding proteins depleted in the normal course of healthy aging. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Madison, WI April 15, 2010 – Memory loss supplement Prevagen is saluting World Health Day 2010 by extending their public service educational activities to cover the entire month of April. Mark Underwood, neuroscience researcher and president of Prevagen’s manufacturer, Quincy Bioscience, is doing a number of educational radio talk shows about the various facets of memory loss (http://www.prevagen.com/MemoryLoss.html) and its impact on health.

Memory loss knows no boundaries and its escalating effects are being experienced by the growing, aging populations of rural, metropolitan, and urban areas all over the world. The World Health Organization (WHO) reports that in almost every country, the proportion of people over 60-years-old is growing faster than any other age group as a result of both longer life expectancy and declining fertility rates.

Underwood, whose interest in neuroscience research began after witnessing two of his family members develop memory loss, says the inability to recall important facts and events can have a detrimental impact on health in unforeseen ways. For example, those with severe food allergies can forget which foods they must not eat, or worse, medications can be taken more often than prescribed, resulting in an overdose.

“Recent research has established that excess calcium within the neurons of the brain is what causes those neurons to die, triggering memory loss‚” says Underwood. “We have researched a naturally-occurring protein that can now be taken orally without a prescription which helps inhibit calcium build-up from occurring, thereby keeping the neurons alive and functional longer. Keeping brains healthy as long as possible is our mission.”

During April’s educational radio campaign, Underwood will talk about his research into memory loss and explain why excess calcium accumulates within our brain cells. He will also explain how memory loss can be delayed or reversed by supplementing the diet with a calcium-binding protein discovered in jellyfish called apoaequorin, the active ingredient in Prevagen.

The World Health Organization is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends. For more information visit http://www.who.int/en/

Memory loss (http://www.prevagen.com/MemoryLoss.html) supplement Prevagen is manufactured by Quincy Bioscience, (http://www.quincybioscience.com) a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company’s products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for use in dietary supplements and pharmaceutical products. The company’s first product, Prevagen, was launched in the fall of 2007 and is intended to supplement the loss of critical calcium-binding proteins depleted in the normal course of healthy aging.

Mar 10, 2010 – Madison, WI – Memory Loss Improvement Study QB-0011 – Prevagen® Memory Study is being announced by Quincy Bioscience for Brain Awareness Week starting March 15th. The new Prevagen Memory Loss Study (http://www.prevagen.com/MemoryLoss.html) will evaluate the impact of Prevagen on cognitive function and other Quality of Life measures. Participants in the study are men and women between the ages of 40-95 experiencing some memory loss who will be using the brain health dietary supplement Prevagen.

Brain Awareness Week (http://www.dana.org/brainweek) is held every March and is a global campaign to increase public awareness about the progress and benefits of brain research. Brain Awareness Week (BAW) unites the efforts of universities, hospitals, patient groups, government agencies, schools, service organizations, and professional associations worldwide in a week-long celebration of the brain. Founded and coordinated by the Dana Alliance for Brain Initiatives and European Dana Alliance for the Brain, BAW is celebrating 15 years of education and outreach about the brain.

The new memory loss study, being announced for BAW by Quincy Biosciences, will use the brain health supplement Prevagen having as its main ingredient a naturally occurring calcium-binding protein discovered in jellyfish called apoaequorin. Prevagen is the first and only product to use this active ingredient.

The study is a randomized placebo-controlled, double-blind study that will require five cognitive testing sessions during the three-month study period. The impact of Prevagen on brain cell protection will be evaluated using computer-based cognitive testing software by Cogstate, Ltd., a leading cognitive testing software company based in Melbourne, Australia.

“We are excited about the new Prevagen Memory Study. We are researching various areas in order to bring hope to people with different health challenges related to aging and memory with the goal of improving quality of life,” says Mark Underwood, Quincy Bioscience president. “Additionally, we are doing a series of educational radio shows during March Brain Awareness Week to help raise brain awareness.”

Memory Loss (http://www.prevagen.com/MemoryLoss.html) Improvement Study with Prevagen is sponsored by Quincy Bioscience, (http://www.quincybioscience.com) a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company’s products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for use in dietary supplements and pharmaceutical products. The company’s first product, Prevagen, was launched in the fall of 2007 and is intended to supplement the loss of critical calcium-binding proteins depleted in the normal course of healthy aging.

Madison, Wis–February 16, 2010
Memory loss (http://www.prevagen.com/MemoryLoss.html) is a big problem for professional football players. The Saints have won the Super Bowl and the question many are beginning to ask concerns the player’s health, “How many of these players will remember the game five or ten years from now?‚Äù

Growing concern over head trauma sustained by athletes, especially football players, has raised questions about how to protect athletes from debilitating conditions such as memory loss. Quincy Bioscience offers promising biotech development of a protein to help regulate calcium in the brain.*

The problem of memory loss in football is gaining widespread attention. Nearly every week this past football season fans heard about a concussion keeping a marquee player sidelined. The N.F.L. was called to congressional hearings this past October to discuss player safety and the changing league policies designed to better protect players after a study was released that found ex-players at a 19 times higher risk of dementia than the general population.

Quincy Bioscience, a Madison Wisconsin-based biotechnology company is developing a technology that may offer help to these athletes through the development of a jellyfish protein which buffers brain calcium. According to Quincy Bioscience president Mark Underwood, “As an apparent protective mechanism, the brain elevates calcium levels within the neurons after a trauma,” says Underwood. “It’s the elevated calcium levels that can inactivate, and potentially kill the neurons, bringing about cognitive dysfunction, memory loss, and in some cases dementia in the athletes.”

Quincy Bioscience launched Prevagen® which contains the jellyfish-derived protective protein. “We have demonstrated the added protein’s ability to keep brain cells alive in animal tissues and we are hopeful these techniques crossover to humans who have suffered trauma to the brain in the past and now find themselves having difficulty thinking, remembering, and concentrating.”*

Quincy Bioscience is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process.

The company’s products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for dietary supplement and pharmaceutical products.

The company’s first product, Prevagen, was launched in the fall of 2007 and is intended to supplement the loss of critical calcium-binding proteins depleted in the normal course of healthy aging.

Madison, Wis February 9, 2010 – The latest report entitled “Keeping Dementia Front of Mind” highlights the prevalence of the brain condition for governments when making policy and budget decisions. Research has shown brainpower peaks in the mid-twenties and then declines and we lose up to 50% of our brain’s capacity by our mid-fifties. Quincy Bioscience is developing a new approach toward this growing problem.

There are 77 million Baby Boomers in the United States are rapidly growing. A discussion about dementia is uncomfortable, but will be impossible to avoid for many. “People are afraid of the unknown and scared of the memory loss they are seeing in aging relatives,” says Quincy Bioscience president Mark Underwood. “However, there is hope coming around the corner.”

Without a breakthrough in the fight against dementia, this number could jump to as many as 84 million who have age-related memory loss by the year 2040. Dementia is a subject avoided by most. Just the thought of memory loss – in a loved one, friend, co-worker or, worse yet, ourselves — makes us terribly uncomfortable. Unless we are confronted directly with dementia, we prefer to think of it as “someone else’s problem.” “Aging is scary and the solutions we have been researching can give people some peace. We now know why the brain loses its “horsepower”by age 55, and we have found a solution in nature to replace this key component.” Underwood continues, referring to his company’s discovery.

The hope lies within some technology developed at Quincy Bioscience, a biotechnology company headquartered in Madison, Wisconsin. They have developed a technology to help keep brain cells alive longer and hopefully to fight the ravages of dementia. “We have demonstrated keeping brain cells alive in animal tissues and these techniques crossover to help with the human mind also.” The key component was isolated in a jellyfish, a protein, a simple component that allows jellyfish to sting, but people not to be “stung” by the age-related changes that lead to dementia.

Underwood states, “Our population is “graying” and our citizens are living much longer than any previous generation. The fastest growing segment of our population is the over 80 age group, and the odds of becoming demented for the very elderly are much higher. So we have to act now, to protect our nation’s best and most precious resources, our brains.”

Quincy Bioscience (www.quincybioscience.com) is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company’s products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for dietary supplement and pharmaceutical products. The company’s first product, Prevagen (www.prevagen.com), was launched in the fall of 2007 and is intended to supplement the loss of critical calcium-binding proteins depleted in the normal course of healthy aging.

Feb 04, 2010 – Madison, WI –
Quincy Bioscience, manufacturer of Prevagen® – a natural brain health supplement to help fight memory loss http://www.prevagen.com, announces their partnership with nationally syndicated radio talk show host John Tesh. The unique jellyfish protein-based product was first introduced in 2007 and has helped thousands with their learning, memory, and concentration.

A partnership between Quincy Bioscience and The John Tesh Radio Show represents the growing story of a jellyfish protein helping improve brain function for people across the United States.

“The John Tesh Radio Show – Intelligence for Your Life is a natural fit for Prevagen®,” says Quincy Bioscience president Mark Underwood. “Mr. Tesh’s program not only entertains his listeners but helps them lead better lives by sharing a wealth of practical information. Prevagen® works well in the format of the program because of the story behind it.”

Prevagen® was launched in 2007 after twelve years of research went into evaluating whether a jellyfish protein could help with brain aging and the troublesome problems like poor recall, difficulty concentrating, and misplacing items that often accompany aging.

Motivated by his own family experiences with neurodegenerative conditions, Mr. Underwood as an undergraduate at the University of Wisconsin-Milwaukee came across research linking stings of a jellyfish with the symptoms of multiple sclerosis. After several years of research isolating the jellyfish protein and proving it could protect brain cells, Prevagen® – Brain Cell Protection was born.

“In quality of life studies, we have shown Prevagen can help people with short-term memory, word recall, and remember driving directions better,” says Underwood. “John Tesh reaches thousands of listeners who face these challenges every day. We’re excited about the opportunity to help them.”

“The John Tesh Radio Show” in 2003 and has since become one of the most listened-to voices on the air. The show has recently won Radio Ink magazine’s Reader’s Poll for “Favorite Syndicated Radio Personality” and airs on over 300 stations nationwide.

Quincy Bioscience (http://www.quincybioscience.com) is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process.

Memory loss symptoms showed an improvement across all parameters in the Prevagen Quality of Life Study conducted by Quincy Bioscience, makers of Prevagen®, a brain cell protection supplement. The study concluded the impact of Prevagen on memory loss reduces forgetfulness, helps word recall, reduced the need for reminders, and improved memory in 90 days.

The Prevagen Quality of Life Study was an open-label of 56 generally healthy participants over a 90-day period measuring changes in overall cognition, quality of sleep, energy, mood, pain, and general health.

The results of the study show improved performance across all parameters, illustrating that Prevagen provides a clear benefit in the area of memory, especially for those who reported having poor memory starting at Day 0 (baseline) of the trial.

Prevagen (10 mg) was taken daily by the trial participants. The study showed a statistically significant improvement in memory after 30 days. 57% of participants had improvement in general memory, 51% in retailing information, 84% in remembering driving instructions, and 66% in word recall.

The brain contains calcium-binding proteins that protect the brain cells and under normal functioning, many cellular processes are closely regulated.

Calcium-binding proteins regulate calcium to keep a balance within the nervous system. As people age, an individual’s production of calcium-binding proteins is reduced. As the calcium-binding proteins decline, calcium is not as closely regulated, leaving brain cells vulnerable. Excess calcium can result in neuronal cell damage and memory impairment.

“Fortunately, Prevagen provides a supplemental source of calcium-binding proteins to protect the cells, helping to restore calcium balance,” explains Mark Underwood, President and co-founder of Quincy Bioscience.

“The calcium-binding proteins that protect our brain cells deplete with age. Prevagen is the only all-natural brain supplement that can replace these proteins and prevent memory loss,” continues Mark Underwood. “This is one more study we’ve conducted with Prevagen showing the benefits a calcium-binding protein supplement on memory loss symptoms, by helping to keep brain cells alive which can result in a healthier brain, a sharper mind, clearer thinking and better memory. To read the Prevagen Quality of Life Study visit http://www.prevagen.com/files/PRV_Memorystudy_packet.pdf,”

Memory loss supplement Prevagen, is manufactured by Quincy Bioscience a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company’s products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for dietary supplement and pharmaceutical products. The company’s first product, Prevagen (www.prevagen.com), was launched in the fall of 2007 and is intended to supplement the loss of critical calcium-binding proteins depleted in the normal course of healthy aging.

Madison, WI – Memory loss and losing brain capacity is the biggest fear of the aging baby boomer population according to research conducted by the Natural Marketing Institute (NMI). Help may be found in a brain supplement called Prevagen® that is based on a new discovery of a jellyfish protein that helps slow memory loss and improves brain health.

The NMI research conducted on the US general population showed that 44 percent of the US adult population has memory loss and losing brain capacity as their biggest fear. More than half of the females (52 percent) reported memory loss/ and losing brain capacity as their biggest fear about aging, significantly more than the males (36 percent).

“Finding a meaningful solution to the escalating memory loss problem has been a key motivator for launching Prevagen, so we were very interested to see this research from NMI,” says Mark Underwood, President and co-founder of Quincy Bioscience. “We have been conducting very exciting clinical studies in the area. We are working on a new approach utilizing a jellyfish protein to help with memory loss and is contained in the brain supplement called Prevagen.”

“Too much calcium within a brain cell impairs its function. The jellyfish protein apoaequorin is remarkably similar to the calcium-binding proteins found in the human nervous system which become depleted in the mental aging process and can lead to cell death or damage, causing forgetfulness as we age,” continues Underwood. “Unfortunately, over time we lose our ability to regulate brain cell calcium. Starting at about forty, our brains produce fewer calcium-binding proteins. This causes calcium levels to rise throughout the nervous system. Neurons are flooded with dangerous levels of calcium and our brains slow down. The jellyfish apoaequorin which is the key ingredient in Prevagen helps regulate this imbalance.”

Human studies have shown that apoaequorin, with its ability to bind to and balance calcium levels, can be used to help replace missing calcium-binding proteins and improve cognitive function and provide greater clarity and alertness. Additional clinical studies are planned.

The memory loss brain supplement, Prevagen, is manufactured by Quincy Bioscience, a Madison, Wisconsin based biotechnology company, focused on the discovery, development and marketing of new compounds to fight the mental aging process. The company’s products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for dietary supplement and pharmaceutical products.

Madison, WI – Memory loss research conducted by Quincy Bioscience laboratories has resulted in a natural brain supplement called Prevagen® that helps slow memory loss and improves brain health. The brain supplement’s key ingredient, Apoaequorin from jellyfish, is a calcium-binding protein that helps protect healthy brain cells from brain cell death which is a cause of memory loss.

Memory loss on any level is a scary proposition for both the person experiencing it and the family members around that person who might be a wife or husband, son, daughter, or friend. Media estimates report that tens of millions of Americans are suffering from slight memory loss with untold impact on families.

Most of us know how important calcium is for healthy bones and teeth. But most people don’t know that calcium plays a far greater role in the body. It’s the element for millions of cellular reactions and is essential for brain cell health. Calcium imbalance in the brain causes cell damage which can lead to forgetfulness.

“Our laboratory research shows that Apoaequorin, the calcium binding protein in Prevagen, helps the nervous system balance calcium which can lead to better memory, focus and concentration,” says Mark Underwood, neuroscience researcher, President and co-founder of Quincy Bioscience. “The technical paper from this research presented at the Society for Neuroscience can be read at www.prevagen.com/science.

Additionally, Quincy Bioscience has hundreds of consumer and caregiver reviews on the benefits of Prevagen and shares this one from JJ of Yakima, WA, “The benefits are far greater than I expected. I play tennis weekly with other people my age and younger, and I always had problems keeping score, until now. I can now recall the score every time. I also no longer fumble trying to remember the names of my 8 grandchildren. I have the brain of a 31 year old now! To see other customer reviews talking about their memory loss visit www.prevagen.com/reviews.html .

The memory loss brain supplement, Prevagen, is manufactured by Quincy Bioscience, a Madison, Wisconsin based biotechnology company, focused on the discovery, development and marketing of new compounds to fight the mental aging process. The company’s products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for dietary supplement and pharmaceutical products. For more information visit www.quincybioscience.com.

Madison, WI February 24, 2009 – A biotech company in Madison, Wisconsin is so concerned about the declining quality of memory among federal government officials that they have volunteered to give away free bottles of brainenhancing supplements to any member of Congress or the incoming administration who has forgotten to pay taxes within the last 10 years.

“We realize that government employees in positions of responsibility have many important issues on their minds. so it’s easy for items on their personal ‚Äòto-do list’ to slip through the memory cracks,” says Quincy Bioscience president Mark Underwood, formulator of the memory-boosting supplement Prevagen®.

“We’re confident that after 30-60 days of taking the supplement, most legislators and government officials will recall, without being reminded by aides or reporters, all tax periods for which they have forgotten to pay state or federal income taxes,” said Underwood.

Underwood says Prevagen is so effective at rehabilitating memory that most government officials will even recall times when they failed to make Social Security and Medicare contributions for undocumented household workers.

Here are a few of the embarrassing situations Underwood says might have been avoided had the officials involved been improving their brain health with Prevagen:

• Back in September, Charles B. Rangel, Chairman of the House Ways and Means Committee, (the committee in charge of writing tax policy for the entire nation), forgot to pay taxes on $75,000 income he received from his rental property in the Dominican Republic.
• Tom Daschle, the former senator from South Dakota was chosen to head the Health and Human Services Department but had to withdraw February 3rd over his failure to pay 128 thousand dollars in taxes in the last two years.
• Nancy Killefer, former Assistant Treasury Secretary under Bill Clinton, was forced to withdraw after President Obama nominated her for the post of Chief Performance Officer when it became known that she had failed for a year and a half to pay employment taxes on household help.
• Treasury Secretary Tim Geithner failed to pay $34,000 in taxes for Social Security and Medicare when he was a senior official at the International Monetary Fund from 2001 to 2003.

“Our goal is to spare our elected and unelected officials in Washington the embarrassment that failing memory often brings,” says Underwood.

Prevagen® is now available in select GNC stores and Rite-Aid Pharmacies and fine health food stores across the United States.